Dynamics of HBsAg clearance in a UK cohort of chronic HBV infection
Hepatitis B surface antigen (HBsAg) has recently gained traction as a biomarker that may provide prognostic information and inform treatment decisions in chronic hepatitis B virus (HBV) infection. It may be particularly useful when HBV DNA levels are low and therefore difficult to quantify accuratel...
Prif Awduron: | Downs, L, Patel, M, Ansari, M, McNaughton, A, Smith, D, Andersson, M, Barnes, E, Jeffery, K, Matthews, P |
---|---|
Fformat: | Conference item |
Cyhoeddwyd: |
Elsevier
2018
|
Eitemau Tebyg
-
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
gan: Shaowen Jiang, et al.
Cyhoeddwyd: (2023-01-01) -
Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients
gan: Hui Liu, et al.
Cyhoeddwyd: (2024-04-01) -
Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes.
gan: Edouard Tuaillon, et al.
Cyhoeddwyd: (2012-01-01) -
Electronic health informatics data to describe clearance dynamics of hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) in chronic hepatitis B virus infection
gan: Downs, L, et al.
Cyhoeddwyd: (2019) -
Investigation of HBV DNA in HBsAg positive patients
gan: Nihal Secil Bati, et al.
Cyhoeddwyd: (2017-12-01)